Psychopharmakotherapie bei älteren Menschen mit schweren psychischen Erkrankungen
- 9 October 2018
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Gerontologie und Geriatrie
- Vol. 51 (7) , 770-778
Abstract
Chronische Schizophrenie, Depression, bipolare Störungen und andere chronische psychische Erkrankungen mit Beginn in Jugend oder jungem Erwachsenenalter werden oft als „severe mental illness“ (SMI) bezeichnet. Altwerden mit einer SMI ist vergesellschaftet mit verschiedenen psychosozialen, physiologischen und medizinischen Besonderheiten mit potenziellem Einfluss auf die Psychopharmakotherapie (PPT).Keywords
This publication has 33 references indexed in Scilit:
- The impact of treatment non-compliance on mortality in people with type 1 diabetesJournal of Diabetes and its Complications, 2013
- Early and Delayed Onset of Response to Antidepressants in Individual Trajectories of Change During Treatment of Major DepressionThe Journal of Clinical Psychiatry, 2011
- Aging With a Severe Mental Illness: Challenges and TreatmentsJournal of Gerontological Social Work, 2011
- Twenty-five year mortality of a community cohort with schizophreniaThe British Journal of Psychiatry, 2010
- Treatment Options for the Patient Who Does Not Respond Well to Initial Antidepressant TherapyJournal of Psychiatric Practice, 2009
- The prevalence of undiagnosed metabolic abnormalities in people with serious mental illnessJournal of Psychopharmacology, 2009
- Increased Antipsychotic Sensitivity in Elderly PatientsThe Journal of Clinical Psychiatry, 2008
- Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable AnginaJAMA, 2002
- Pharmacy Data Identify Poorly Adherent Patients With Schizophrenia at Increased Risk for AdmissionMedical Care, 2002
- Factors influencing relapse in the long-term course of schizophreniaSchizophrenia Research, 1997